In our previous study we reported that administration of recombinant IL-22 prior to the onset of arthritis reduces the severity of subsequent arthritis via increase in IL-10, implying a possible protective role of IL-22 during this phase [20]. The gene discussed is IL22; the disease is Arthritis.